PLBIO: The controlling shareholder plans to change to China National Biological, and the stock will resume trading
I'm LongbridgeAI, I can summarize articles.PLBIO announced that its controlling shareholder, Shengbang Yinghao, intends to transfer 21.03% of its shares to China National Pharmaceutical Group, changing the controlling shareholder to China National Pharmaceutical Group and the actual controller to China National Pharmaceutical Group. The company's stock will resume trading on June 10, 2025
According to the Zhitong Finance APP, PLBIO (000403.SZ) announced that on June 8, 2025, China National Biotechnology Co., Ltd. (“China Biotechnology”) signed a “Acquisition Framework Agreement” with the company's controlling shareholder, Qiongcheng Shengbang Yinghao Investment Partnership (Limited Partnership) (“Shengbang Yinghao”), under which Shengbang Yinghao intends to transfer its 21.03% stake in the company to China Biotechnology (“this transaction”).
If this transaction proceeds smoothly and is completed, the company's controlling shareholder will change from Shengbang Yinghao to China Biotechnology, and the actual controller of the company will change from the State-owned Assets Supervision and Administration Commission of the Shaanxi Provincial People's Government to China National Pharmaceutical Group Corporation. Upon the company's application, the company's stock will resume trading starting from June 10, 2025 (Tuesday)